Overview
Feline calicivirus (FCV) is a highly contagious, non-enveloped, single-stranded RNA virus belonging to the Caliciviridae family, primarily affecting domestic cats worldwide 12. FCV is one of the leading causes of upper respiratory tract disease (URTD) in cats, often presenting with oral ulcerations, hypersalivation, and chronic gingivostomatitis, alongside respiratory symptoms 134. In severe cases, particularly with virulent systemic FCV (VS-FCV) strains, FCV can lead to high mortality rates in multicat environments 15. Clinicians must recognize FCV due to its potential for outbreaks and the variability in clinical presentations, ranging from mild to life-threatening conditions, impacting both individual cats and entire populations 16.Pathophysiology
FCV infection initiates with viral attachment to host cells via the cellular receptor feline junctional adhesion molecule A (fJAM-A), located at tight junctions of epithelial cells 27. This interaction disrupts cellular integrity, leading to ulcerations in the oral mucosa and other epithelial surfaces 28. The virus replicates within host cells, utilizing its three open reading frames (ORFs) to produce essential proteins: ORF1 generates non-structural proteins crucial for viral replication, ORF2 produces the major capsid protein (VP1) and a leader protein, and ORF3 encodes the minor capsid protein (VP2) involved in genome release 29. Genetic variability within FCV strains contributes to diverse clinical outcomes, with some strains causing severe systemic disease and others leading to milder, localized symptoms 210. The immune response, particularly the role of neutralizing antibodies targeting specific epitopes on VP1, plays a critical role in controlling infection but can also be evaded by certain viral mutations 211.Epidemiology
FCV is prevalent globally among domestic cats, with no significant differences noted in incidence based on age, sex, or geographic location 12. However, multicat environments such as shelters, catteries, and households with multiple cats are at higher risk due to increased transmission rates 112. Over time, the virus has shown high genetic plasticity, leading to the emergence of more virulent strains capable of causing severe outbreaks with high mortality rates 113. Despite this, specific incidence and prevalence figures are not consistently reported across different regions, making precise epidemiological trends challenging to delineate 114.Clinical Presentation
FCV infection typically manifests with oral ulcerations, characterized by painful lesions in the mouth and tongue, often accompanied by hypersalivation and difficulty eating 13. Respiratory symptoms such as sneezing, nasal discharge, and conjunctivitis are also common, though less frequently reported than oral lesions 14. Atypical presentations include limping syndrome, chronic gingivostomatitis, and severe systemic disease with multi-organ involvement, particularly in virulent strains 15. Red-flag features include high fever, lethargy, anorexia, and significant weight loss, which may indicate severe systemic infection requiring urgent intervention 16.Diagnosis
The diagnosis of FCV infection involves a combination of clinical signs, laboratory testing, and sometimes molecular methods. Diagnostic Approach:Specific Criteria and Tests:
Management
First-Line Management:Second-Line Management:
Refractory Cases:
Monitoring:
Complications
Acute Complications:Long-Term Complications:
Management Triggers:
Prognosis & Follow-Up
The prognosis for FCV infection varies widely depending on the virulence of the strain and the cat's overall health. Cats with mild to moderate infections generally recover with supportive care, often within weeks 112. Prognostic indicators include rapid viral clearance, absence of secondary infections, and prompt resolution of clinical signs. Follow-Up Recommendations:Special Populations
Kittens: More susceptible to severe forms of FCV, including pneumonia, due to immature immune systems 114.Adult Cats with Chronic Conditions: Cats with pre-existing conditions like chronic kidney disease or immunodeficiency may experience more severe outcomes 115.
Key Recommendations
References
1 Synowiec A, Pachota M, Krejmer-Rabalska M, Ziemann D, Szczubiałka K, Jank M et al.. Antiviral effect of poly(styrene 4-sulfonate) (PSSNa) on feline calicivirus oral infections in cats-field study. The veterinary quarterly 2026. link 2 Hofmann-Lehmann R, Hosie MJ, Hartmann K, Egberink H, Truyen U, Tasker S et al.. Calicivirus Infection in Cats. Viruses 2022. link 3 Saade DI, Liu CC, Mills EP, Stanfield B, Thieulent CJ, Chouljenko VN et al.. Replication kinetics and cytopathic effect of feline calicivirus in feline corneal epithelial cells. Veterinary ophthalmology 2026. link 4 Spiri AM. An Update on Feline Calicivirus. Schweizer Archiv fur Tierheilkunde 2022. link 5 Johnson RP, Povey RC. Feline calicivirus infection in kittens borne by cats persistently infected with the virus. Research in veterinary science 1984. link